Nu Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 173,553 | 121,887 | 129,437 | 143,086 | 133,046 |
| Depreciation Amortization | 76,650 | 83,003 | 71,564 | 72,397 | 71,365 |
| Income taxes - deferred | 1,965 | -14,929 | 39,213 | -17,652 | 17,362 |
| Accounts receivable | 2,746 | -10,453 | -103 | 3,357 | -2,246 |
| Accounts payable and accrued liabilities | -7,184 | -9,164 | 6,834 | 13,443 | -4,297 |
| Other Working Capital | -132,435 | -71,884 | 47,089 | 28,324 | 65,701 |
| Other Operating Activity | 62,636 | 104,278 | 8,521 | 32,308 | 41,178 |
| Operating Cash Flow | $177,931 | $202,738 | $302,555 | $275,263 | $322,109 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66,067 | -70,371 | -60,156 | -50,221 | -56,622 |
| Net Acquisitions | -8,073 | -38,506 | -31,745 | -8,692 | N/A |
| Purchase Of Investment | -8,432 | -11,420 | -11,332 | -17,080 | -15,750 |
| Sale Of Investment | 11,160 | 11,536 | 11,269 | 18,132 | 11,526 |
| Investing Cash Flow | $-71,412 | $-108,761 | $-91,964 | $-57,861 | $-60,846 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 145,000 | 582,398 | 67,000 | 233,721 | 36,217 |
| Debt Repayment | -214,455 | -552,500 | -103,226 | -56,151 | -35,508 |
| Common Stock Issued | -2,325 | 10,777 | 24,443 | 14,307 | 3,315 |
| Common Stock Repurchased | -825 | -69,565 | -71,731 | -247,208 | -164,094 |
| Dividend Paid | -82,189 | -80,581 | -76,058 | -78,438 | -81,187 |
| Other Financing Activity | 0 | -7,243 | 0 | -945 | 5,337 |
| Financing Cash Flow | $-154,794 | $-116,714 | $-159,572 | $-134,714 | $-235,920 |
| Exchange Rate Effect | -3,006 | -16,751 | 18,134 | -14,796 | -24,404 |
| Beginning Cash Position | 386,911 | 426,399 | 357,246 | 289,354 | 288,415 |
| End Cash Position | 335,630 | 386,911 | 426,399 | 357,246 | 289,354 |
| Net Cash Flow | $-51,281 | $-39,488 | $69,153 | $67,892 | $939 |
| Free Cash Flow | |||||
| Operating Cash Flow | 177,931 | 202,738 | 302,555 | 275,263 | 322,109 |
| Capital Expenditure | -66,067 | -70,371 | -60,156 | -50,221 | -56,622 |
| Free Cash Flow | 111,864 | 132,367 | 242,399 | 225,042 | 265,487 |